Tonix Pharmaceuticals Holding Corp

NASDAQ:TNXP   2:45:52 PM EDT
1.07
+0.10 (+9.79%)
Other Pre-Announcement

Tonix Pharmaceuticals Reports Q4 Loss Per Share Of $0.10

Published: 03/15/2021 21:01 GMT
Tonix Pharmaceuticals Holding Corp (TNXP) - Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights.
Q4 Loss per Share $0.10.
Tonix Pharmaceuticals Holding - at December 31, 2020, Cash and Cash Equivalents Totaled $77.1 Million.
Phase 1 Safety Study in Humans of Tnx-1800 Expected to Start in Second Half 2021.